Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients

NCT04341207 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Cancer & COVID 19

Interventions

DRUG: Hydroxychloroquine
DRUG: Azithromycin

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris